Unanswered Questions: AML with IDH Mutations
The optimal induction regimen for intensive chemotherapy-eligible patients with IDH-mutated AML has not been established. In our recently published study, we report outcomes of newly diagnosed IDH-mutated AML treated with intensive chemotherapy plus venetoclax, highlighting efficacy and challenges.
A Genomic Wake-Up Call: Rethinking Breast Cancer Through the African Lens
In our recent NPJ Breast Cancer study, we reviewed all available data on breast cancer mutations in African populations—revealing distinct genetic patterns and major gaps in current knowledge.
